Mexazolam
Discover related
2 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| TripSit | Pharmacology | ||
|---|---|---|---|
| Classification | |||
| Class / category | — | ||
| Also known as | melexsedoxil | — | |
| Safety | |||
| Dose · Oral | |||
| Light | 0.25–0.5 mg | — | |
| Common | 0.5–1.5 mg | — | |
| Strong | 1.5–2 mg | — | |
| Heavy | 2 mg+ | — | |
| Duration | |||
| Onset | 5–45 minutes | — | |
| Total | 4–8 hours | — | |
| After-effects | 1–12 hours | — | |
| Pharmacology | |||
| Half-life | — | Mexazolam follows a 2 compartment model with a first half life of 1.4h and a second half life of 76h. | |
| Protein binding | — | Mexazolam is >90% protein bound in plasma. | |
TripSit summary
Benzodiazepine derivative that has been trialed for anxiety and was found to be effective for anxiety at one week week follow-ups yet after three weeks it had lost its therapeutic anxiolytic properties and becoming no more effective than placebo.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.